3,4,5-Trihydroxybenzoic Acid Attenuates Ligature-Induced Periodontal Disease in Wistar Rats

Area of Science:

• Periodontology
• Pharmacology
• Biochemistry

Background:

• Periodontitis is an inflammatory condition affecting the tissues supporting teeth.
• Gallic acid (3,4,5-Trihydroxybenzoic acid) is recognized for its anti-inflammatory properties.
• This study investigates gallic acid's potential in managing experimental periodontitis.

Purpose of the Study:

• To evaluate the anti-inflammatory efficacy of gallic acid in a rat model of periodontitis.
• To assess the impact of gallic acid on key indicators of periodontal disease, including bone loss and cellular activity.

Main Methods:

• Experimental periodontitis was induced in Wistar rats using silk sutures.
• Rats were treated with two doses of gallic acid (30 mg/kg and 60 mg/kg) or served as controls.
• Histological and stereomicroscopic analyses evaluated alveolar bone loss, osteoclast/osteoblast activity, and inflammatory markers.

Main Results:

• Gallic acid administration significantly reduced alveolar bone loss compared to the periodontitis control group.
• Gallic acid treatment decreased tartrate-resistant acid phosphatase (TRAP)-positive osteoclast counts and increased osteoblast numbers.
• Inflammatory cell counts, matrix metalloproteinase (MMP)-8 levels were reduced, while tissue inhibitor of MMPs (TIMP)-1 and bone morphogenetic protein (BMP)-2 levels increased with gallic acid treatment.

Conclusions:

• Gallic acid exhibits significant anti-inflammatory effects in experimental periodontitis.
• The compound effectively mitigates alveolar bone loss and modulates cellular activity related to bone remodeling.
• Gallic acid shows promise as a therapeutic agent for preventing and treating periodontal inflammation.